摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3,4-二甲氧基苯基)甲硫醇 | 54810-59-2

中文名称
(3,4-二甲氧基苯基)甲硫醇
中文别名
——
英文名称
3,4-dimethoxytoluene-α-thiol
英文别名
3,4-dimethoxybenzyl mercaptane;3,4-dimethoxybenzyl thiol;(3,4-dimethoxy-phenyl)-methanethiol;(3,4-Dimethoxy-phenyl)-methanthiol;3,4-Dimethoxytoluol-α-thiol;3,4-Dimethoxybenzylmercaptan;(3,4-Dimethoxyphenyl)methanethiol
(3,4-二甲氧基苯基)甲硫醇化学式
CAS
54810-59-2
化学式
C9H12O2S
mdl
——
分子量
184.259
InChiKey
LCYWBZHEAHZANR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    19.5
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:7b88b07c840c8dafcafcf1362d6e345f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Oxidative Biaryl Coupling Reaction of Phenol Ether Derivatives Using a Hypervalent Iodine(III) Reagent
    摘要:
    The hypervalent iodine(III)-induced intramolecular biaryl coupling reaction of phenol ether derivatives (nonphenolic derivatives) was investigated with the aim of preparing various dibenzo heterocyclic compounds. 1,3-Diarylpropanes (1a-e), N-benzyl-N-phenethylamines (2a-c) and N,N-dibenzylamines (3a-e) react with a hypervalent iodine reagent, phenyliodine(III) bis(trifluoroacetate) (PIFA), containing BF3. Et2O in CH2Cl2 to give the biaryl coupling products (4-6) in good yield. As an application of the reaction, we examined the synthesis of oxygen- and sulfur-containing dibenzoheterocyclic compounds (12-15), whose side chain moiety could be easily cleaved by the known method to give 2,2'-substituted biphenyl compounds (16-18).
    DOI:
    10.1021/jo980704f
  • 作为产物:
    参考文献:
    名称:
    Jenny, Corrosion et Anticorrosion, 1956, vol. 4, p. 4,15
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Facile aromatic nucleophilic substitution (S<sub>N</sub>Ar) reactions in ionic liquids: an electrophile–nucleophile dual activation by [Omim]Br for the reaction
    作者:Xiao Zhang、Guo-ping Lu、Chun Cai
    DOI:10.1039/c6gc01742h
    日期:——
    A facile aromatic nucleophilic substitution reaction (SNAr) in recyclable [Omim]Br under relatively mild conditions has been described. An electrophile-nucleophile dual activation by [Omim]Br is also discovered based on control experiments,...
    已经描述了在相对温和的条件下在可再循环的[Omim] Br中的容易的芳族亲核取代反应(SNAr)。基于对照实验,还发现了[Omim] Br引起的亲电亲核双重激活,...
  • DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS
    申请人:Chiesi Farmaceutici S.p.A.
    公开号:US20130079313A1
    公开(公告)日:2013-03-28
    The invention relates to inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are derivatives of 1-phenyl-2-pyridinyl alkyl alcohols, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
    这项发明涉及磷酸二酯酶4(PDE4)的抑制剂。更具体地,该发明涉及1-苯基-2-吡啶基烷基醇衍生物,制备这类化合物的方法,含有它们的组合物以及它们的治疗用途。
  • The thio-adduct facilitated, enzymatic kinetic resolution of 4-hydroxycyclopentenone and 4-hydroxycyclohexenone
    作者:Aisling O'Byrne、Cian Murray、Dearbhla Keegan、Carole Palacio、Paul Evans、Ben S. Morgan
    DOI:10.1039/b916506a
    日期:——
    The addition of 3,4-dimethoxybenzyl thiol 8, as a benzyl thiol surrogate, to racemic 4-hydroxycyclopent-2-enone 2 and 4-hydroxycyclohex-2-enone 15 gave the corresponding cis-adducts (±)-3-(3,4-dimethoxybenzylthio)-4-hydroxycyclopentanone 4b and (±)-3-(3,4-dimethoxybenzylthio)-4-hydroxycyclohexanone 16 with good diastereocontrol. In both cases, subsequent treatment with vinyl acetate, in the presence of a lipase enabled enantiomer resolution. Thus, (+)-16 and the acetate of its enantiomer, (–)-(1R,2S)-2-(3,4-dimethoxybenzylthio)-4-oxocyclohexyl acetate, (–)-17 were isolated in 98% enantiomeric excess. Based on the 1,4-dioxygenation pattern, (–)-17 can be used to prepare both enantiomers of 4-(tert-butyldimethylsilyloxy)cyclohex-2-enone 19. Firstly, saponification, with a sub-stoichiometric amount of NaOMe, followed by a one-pot silyl ether formation–sulfide elimination sequence gave (+)-19. Then using the same starting material a 6-step sequence, featuring a diastereoselective NaBH4 reduction and a Cope-type sulfoxide elimination, gave (–)-19.
    将 3,4-二甲氧基苄基硫醇 8(作为苄基硫醇的代用品)加到外消旋 4-羟基环戊-2-烯酮 2 和 4-羟基环己-2-烯酮 15 中,可得到相应的顺式加成物 (±)-3-(3、(±)-3-(3,4-二甲氧基苄硫基)-4-羟基环戊酮 4b 和 (±)-3-(3,4-二甲氧基苄硫基)-4-羟基环己酮 16。在这两种情况下,随后在脂肪酶存在下用乙酸乙烯酯进行处理,都能实现对映体的解析。因此,(+)-16 及其对映体(-)-(1R,2S)-2-(3,4-二甲氧基苄硫基)-4-氧代环己基乙酸酯(-)-17 的对映体过量率为 98%。根据 1,4-二氧代模式,(-)-17 可用于制备 4-(叔丁基二甲基硅氧基)环己-2-烯酮 19 的两种对映体。首先,使用亚几何量的 NaOMe 进行皂化,然后通过硅醚形成-硫化物消除的一锅式顺序制备出 (+)-19。然后使用相同的起始原料,经过 6 个步骤,包括非对映选择性 NaBH4 还原和 Cope 型亚砜消除,得到了 (-)-19。
  • Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them
    申请人:Seikagaku Corporation
    公开号:US20030153788A1
    公开(公告)日:2003-08-14
    The present invention is to provide manufacturing intermediates which can be led to useful &agr;-ketoamide compounds having protease-inhibiting activity extremely economically and stereoselectively, and to provide epoxycarboxamide compounds, azide compounds and amino alcohol compounds represented by the following formulae: 1 wherein R 1 and R 2 each represents alkyl group, alkenyl group, aromatic hydrocarbon group or heterocyclic group; R 3 represents alkyl group, alkenyl group, aromatic hydrocarbon group, heterocyclic group, R 6 —O— or R 7 —N(R 8 )—; where R 6 represents alkyl group, alkenyl group, aromatic hydrocarbon group or heterocyclic group; R 7 and R 8 each represents hydrogen atom, alkyl group, alkenyl group, aromatic hydrocarbon group or heterocyclic group, and, R 4 and R 5 represent the same groups as R 7 and R 8 , respectively, and R 4 and R 5 optionally form a ring together; and X represents —O— or —N(R 9 )—, where R 9 represents hydrogen atom or alkyl group, and X optionally forms a ring together with R 4 or R 5 , and processes for preparing &agr;-keto amide compound using the same.
    本发明旨在提供制造中间体,以极其经济和立体选择性地导向有蛋白酶抑制活性的有用α-酮酰胺化合物,并提供由以下式表示的环氧羧酰胺化合物,叠氮化合物和氨基醇化合物:其中R1和R2分别表示烷基,烯基,芳香族烃基或杂环基;R3表示烷基,烯基,芳香族烃基,杂环基,R6-O-或R7-N(R8)-;其中R6表示烷基,烯基,芳香族烃基或杂环基;R7和R8分别表示氢原子,烷基,烯基,芳香族烃基或杂环基,而R4和R5分别表示与R7和R8相同的基团,R4和R5可选择性地共同形成环;X表示-O-或-N(R9)-,其中R9表示氢原子或烷基,X可选择性地与R4或R5共同形成环,以及使用它们制备α-酮酰胺化合物的方法。
  • SYNTHESIS OF RESVERATROL-BASED NATURAL PRODUCTS
    申请人:Snyder Scott Alan
    公开号:US20100247462A1
    公开(公告)日:2010-09-30
    Processes for synthesizing resveratrol-based oligomers are provided. In addition, resveratrol-based oligomer compounds free of plant extract are provided.
    提供了合成白藜芦醇基寡聚物的过程。此外,还提供了不含植物提取物的白藜芦醇基寡聚物化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐